Clinical trial · Observational
Impact of the Procurement Technique on Outcomes After Liver Transplantation
Impact of the Procurement Technique on Outcomes After Liver Transplantation: a French Multicenter Prospective Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Liver transplantation (LT) is the standard treatment for hepatocellular carcinoma (HCC) and end-stage liver disease, with excellent long-term outcomes despite the increasing use of extended criteria donors due to organ shortage. As traditional evaluation criteria have become insufficient, new indicators such as Arterial and Biliary Complication-Free Survival (ABCFS) have been developed to better assess post-transplant outcomes. Primary objective: To assess, in a large-scale study, whether the procurement technique influences liver transplantation outcomes in terms of arterial and biliary complication-free survival.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Transplantation | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Arterial and Biliary Complication-Free Survival (ABCFS) at 3 years
- timeFrame
- at 3 years post-transplantation
Secondary outcomes (7)
- measure
- Postoperative complications at 90 days
- timeFrame
- at 90 days post-transplantation
- measure
- Type of Biliary complications
- timeFrame
- Up to 3 years post-transplantation
- measure
- Type of Arterial complications
- timeFrame
- Up to 3 years post-transplantation
- measure
- Occurrence of vascular injuries observed following organ procurement
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients aged 18 years or older at the time of inclusion 2. Listed on the national waiting list of the Agence de la Biomédecine (ABM) 3. Undergoing a first liver transplantation in France 4. Receiving a whole liver graft 5. No prior or subsequent transplantation of another organ Exclusion Criteria: 1. Pancreas procurement 2. Multiorgan transplantation 3. Split liver transplantation (shared grafts) 4. Retransplantation 5. Domino transplantation (no actual organ procurement in the conventional sense) 6. Patient refusal to allow the use of their data
References
Publications (0)
Data not yet available